Exploring how blood vessel damage affects breathing difficulties in patients with ARDS
Investigating the Role of Vascular Injury and Physiologic Dead Space in the Acute Respiratory Distress Syndrome - Supplement
This study is looking at how damage to blood vessels affects the seriousness of lung problems in people with Acute Respiratory Distress Syndrome (ARDS), and it hopes to find clues in the blood that can help doctors give better, more tailored treatments to patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11271544 on NIH RePORTER |
What this research studies
This research investigates the impact of vascular injury on the severity of Acute Respiratory Distress Syndrome (ARDS). It aims to identify biological markers in the blood that could indicate how severe a patient's lung condition is. By analyzing large datasets and using advanced techniques like transcriptomic analysis, the study seeks to improve understanding of ARDS and its outcomes. Patients may benefit from more personalized treatment approaches based on their specific biological responses.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with Acute Respiratory Distress Syndrome.
Not a fit: Patients with chronic respiratory conditions unrelated to ARDS may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment strategies for patients suffering from ARDS.
How similar studies have performed: Previous research has shown promise in understanding ARDS through similar biological and clinical approaches, indicating potential for success in this area.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Costa Monteiro, Ana Carolina — University of California Los Angeles
- Study coordinator: Costa Monteiro, Ana Carolina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.